New Key Statistics Module, Z-Score and F-Score
SZSE:300401 Key Ratios
Market Cap ¥ M | 9,081.28 |
Enterprise Value ¥ M | 8,634.07 |
P/E(ttm) | 37.13 |
PE Ratio without NRI | 40.96 |
Forward PE Ratio | 20.70 |
Price/Book | 2.89 |
Price/Sales | 9.20 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.17 |
Revenue (TTM) ¥ M | 1,134.00 |
EPS (TTM) ¥ | 0.45 |
Beneish M-Score | -2.17 |
10-y EBITDA Growth Rate % | 27.30 |
5-y EBITDA Growth Rate % | -1.80 |
y-y EBITDA Growth Rate % | 36.10 |
EV-to-EBIT | 24.39 |
EV-to-EBITDA | 24.39 |
PEG | -- |
Shares Outstanding M | 543.46 |
Net Margin (%) | 25.11 |
Operating Margin % | 27.20 |
Pre-tax Margin (%) | 28.18 |
Quick Ratio | 1.47 |
Current Ratio | 2.14 |
ROA % (ttm) | 5.23 |
ROE % (ttm) | 9.49 |
ROIC % (ttm) | 7.31 |
Dividend Yield % | 0.42 |
Altman Z-Score | 3.30 |
SZSE:300401 Number of Guru Trades
SZSE:300401 Volume of Guru Trades
Gurus Latest Trades with SZSE:300401
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300401 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Garden Biopharmaceutical Co Ltd Insider Transactions
No Available Data